BERTON, ALESSANDRO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.129
AS - Asia 1.707
EU - Europa 1.080
SA - Sud America 224
AF - Africa 50
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.195
Nazione #
US - Stati Uniti d'America 2.054
SG - Singapore 805
IT - Italia 475
CN - Cina 361
VN - Vietnam 177
BR - Brasile 168
KR - Corea 93
DE - Germania 86
SE - Svezia 85
FR - Francia 81
IE - Irlanda 75
FI - Finlandia 70
HK - Hong Kong 59
IN - India 54
GB - Regno Unito 48
MX - Messico 29
AT - Austria 26
CA - Canada 26
UA - Ucraina 25
JP - Giappone 24
BD - Bangladesh 20
AR - Argentina 19
RU - Federazione Russa 17
NL - Olanda 16
CR - Costa Rica 13
ID - Indonesia 13
IQ - Iraq 13
PL - Polonia 13
PH - Filippine 12
UZ - Uzbekistan 12
CO - Colombia 10
ES - Italia 10
DZ - Algeria 9
AZ - Azerbaigian 8
BE - Belgio 8
EC - Ecuador 8
MA - Marocco 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
PT - Portogallo 7
LT - Lituania 6
OM - Oman 6
PK - Pakistan 6
ET - Etiopia 5
IL - Israele 5
KE - Kenya 5
PY - Paraguay 5
BO - Bolivia 4
EG - Egitto 4
PE - Perù 4
TH - Thailandia 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
CL - Cile 3
CZ - Repubblica Ceca 3
GR - Grecia 3
RO - Romania 3
SA - Arabia Saudita 3
AL - Albania 2
CG - Congo 2
CY - Cipro 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TR - Turchia 2
TW - Taiwan 2
VE - Venezuela 2
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
TN - Tunisia 1
Totale 5.192
Città #
Singapore 468
Ashburn 264
San Jose 239
Chandler 228
Santa Clara 166
Beijing 116
Seoul 89
Hefei 85
Turin 84
Dublin 75
Ho Chi Minh City 61
Los Angeles 58
Hong Kong 52
Houston 51
Dallas 46
Nyköping 46
Torino 45
Lauterbourg 43
Milan 41
Munich 39
Fairfield 38
Hanoi 38
Columbus 37
Turku 37
The Dalles 36
Bengaluru 30
New York 29
Buffalo 27
Vienna 25
Rome 24
Ann Arbor 23
Medford 22
Helsinki 21
Cambridge 19
Orem 19
Boardman 18
Princeton 18
Tokyo 17
Seattle 16
São Paulo 16
London 15
Redondo Beach 15
Dearborn 14
Jacksonville 14
Wilmington 13
Boston 12
Fremont 12
Mexico City 12
Warsaw 12
Woodbridge 12
Frankfurt am Main 11
Frisco 10
Stockholm 10
Villeurbanne 10
Da Nang 9
Hangzhou 9
Toronto 9
Brussels 8
Council Bluffs 8
Dong Ket 8
Falkenstein 8
Hebei 8
Lappeenranta 8
Montreal 8
Pisa 8
Alajuela 7
Albignasego 7
Baku 7
Jakarta 7
Washington 7
Bologna 6
Chicago 6
Florence 6
Guangzhou 6
Haiphong 6
Nuremberg 6
San Mateo 6
Addis Ababa 5
Belo Horizonte 5
Chennai 5
Dhaka 5
Muscat 5
Münster 5
Nairobi 5
Novara 5
Palermo 5
Piossasco 5
Rio de Janeiro 5
San Francisco 5
San Giuliano Milanese 5
San José 5
Alessandria 4
Bogotá 4
Casorezzo 4
Lima 4
Memphis 4
Moscow 4
Mumbai 4
Nanjing 4
Ninh Bình 4
Totale 3.252
Nome #
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease 362
Acromegaly is associated with increased cancer risk: a survey in Italy 261
USEFULNESS OF AN AD HOC QUESTIONNAIRE (ACRO-CQ) FOR THE SYSTEMATIC ASSESSMENT OF ACROMEGALY COMORBIDITIES AT DIAGNOSIS AND THEIR MANAGEMENT AT FOLLOW-UP 227
Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass 183
L'ipopituitarismo post trauma cranico: dall'età pediatrica all'età adulta 173
Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: A systematic review and meta-analysis 163
Association of Urine Metanephrine Levels with Cardiometabolic Risk: An Observational Retrospective Study 134
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study 128
Early copeptin determination allows prompt diagnosis of post-neurosurgical central diabetes insipidus 128
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study 125
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 124
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients 124
Neuroendocrine response to diclofenac in healthy subjects: a pilot study 123
MORNING SERUM CORTISOL LEVEL PREDICTS CENTRAL ADRENAL INSUFFICIENCY DIAGNOSED BY INSULIN TOLERANCE TEST 122
Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests 121
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment 119
Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone 112
Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions 110
Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia? 108
Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. 108
Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view 94
Psychiatric disorders and anger in patients with controlled acromegaly 92
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test 92
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center 91
Skeletal fragility in pituitary disease: how can we predict fracture risk? 88
Impatto socio economico dei trattamenti 88
Association of type 1 stiff-person syndrome and insulinoma: a case report and narrative review 87
Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study 84
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas 83
Long-term efficacy of empagliflozin as an add-on treatment for chronic SIAD: a case report and literature review 83
Trabecular Bone Score as an Index of Bone Fragility in Patients with Acromegaly: A Systematic Review and Meta-Analysis. 83
GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency? 82
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy 79
Isolated anterior pituitary dysfunction in adulthood 78
Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives 75
Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission 73
Endocrinologists at work: management of hyponatremia in clinical practice 71
Mild hyponatremia is not associated with degradation of trabecular bone microarchitecture despite bone mass loss. 69
MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis 68
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience. 67
Evaluation of fluid status in patients with acromegaly through bioelectrical impedance vector analysis: a cross-sectional study 65
Radiomic Analysis in Pituitary Tumors: Current Knowledge and Future Perspectives 63
Growth Hormone-Secreting Pituitary Adenoma: Dura Mater Invasion Is Not a Predictor of Acromegaly Persistence After Trans-Sphenoidal Surgery 62
Reassessing the role of copeptin in emergency department admissions for hypotonic hyponatremia 61
Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery. 60
Isolated third cranial nerve palsy associated with sudden worsening of hypotonic hyponatremia secondary to ischemic pituitary apoplexy 59
Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly. 58
Exploring factors behind Arginine-Vasopressine deficiency in endoscopic endonasal surgery for PitNET: a single-center analysis of 349 patients 53
Diagnostic delay, older age, and hormonal levels at diagnosis affect disease burden and mortality in acromegaly 48
How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients 36
The Impact of the G6PD Gene Mutations in Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals: A Multicenter Observational Study 22
Secondary Pituitary Hyperplasia: The Long-Term Consequences of Untreated Primary Hormonal Deficiencies 20
Severe hypothyroidism as a trigger for Brugada-type ECG abnormalities: a case report and literature review 20
Morning cortisol and central adrenal insufficiency: new thresholds from low-dose ACTH test and second-generation assay 15
NOVEL BIOMARKERS TO GUIDE GLUCOCORTICOID REPLACEMENT IN PRIMARY ADRENAL INSUFFICIENCY: A PROOF-OF-CONCEPT STUDY USING COPEPTIN-DERIVED RATIOS 13
Challenges and unmet needs in diagnosing polyuria-polydipsia syndrome: National survey by the Italian Society of Endocrinology 12
Totale 5.349
Categoria #
all - tutte 19.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022315 30 11 15 22 22 22 16 11 20 17 78 51
2022/2023584 47 59 9 65 54 114 29 36 72 36 41 22
2023/2024332 35 45 14 20 19 33 29 37 7 31 21 41
2024/20251.203 10 70 22 103 265 83 12 47 141 60 160 230
2025/20262.374 323 188 131 288 303 106 430 78 174 187 132 34
Totale 5.349